(Q37812009)

23 August 2017

Using gene expression profiling to predict response and prognosis in gastrointestinal cancers-the promise and the perils (English)

1 reference

23 August 2017

Kate H Brettingham-Moore

1

1 reference

23 August 2017

5

0 references

author name string

Cuong P Duong

2

1 reference

23 August 2017

Alexander G Heriot

3

1 reference

23 August 2017

Robert J S Thomas

4

1 reference

23 August 2017

23 November 2010

1 reference

Annals of Surgical Oncology

23 August 2017

1 reference

23 August 2017

18

1 reference

23 August 2017

5

1 reference

23 August 2017

1484-1491

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-010-1433-1

23 August 2017

0 references

cites work

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

MicroRNA expression profiles for the NCI-60 cancer cell panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Microarray-based response prediction in esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Gene expression profile predicts patient survival of gastric cancer after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Molecular staging for survival prediction of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Gene expression reveals two distinct groups of anal carcinomas with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

Oncogenic pathway combinations predict clinical prognosis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1433-1

10.1245/S10434-010-1433-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference